By Debdeep Gupta | 30 Jul, 2025
Sun Pharma Q1 Preview: Earnings likely to rise on India, specialty strength; margin impact from new launches
Sun Pharmaceutical Industries is set to announce its Q1FY26 results on August 1, with analysts expecting a steady topline and bottom-line performance supported by strong India growth and sequential improvement in the US specialty business. However, higher investments towards product launches and R&D are likely to exert some pressure on margins.According to a Moneycontrol poll, Sun Pharma’s conso...